In this way, a blockade of CD4+ T cells recruitment to the intestine and liver ameliorated hepatic inflammation and fibrosis while improving NASH-associated metabolic dysfunction in a western diet-induced NAFLD model [153]. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.